Clinical Trial Update: Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether dapagliflozin reduces central blood pressure in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: IInstituto Gallego de Medicina Vascular | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN